Picture of Klaria Pharma Holding AB (publ) logo

KLAR — Klaria Pharma Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Klaria Sumatriptan Alginate Film Receives Marketing Authorization

Aug 14 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * KLARIA SUMATRIPTAN ALGINATE FILM RECEIVES MARKETING
AUTHORIZATION
    * MARKETING AUTHORIZATION FOR TREATMENT OF MIGRAINE WITH AND
WITHOUT AURA IS GRANTED.
    * IS IN LICENSING DISCUSSIONS LED BY ERNST AND YOUNG WHICH
WOULD
COVER ALL MAJOR MARKETS IN EU AND MOST MEMBER STATES, INCLUDING
UK, REPRESENTING OVER 30 MILLION PATIENTS

Source text for Eikon:  ID:nWkr8Hw4j 
Further company coverage:  KLAR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Klaria Pharma Holding AB (publ)

See all news